Efficacy and Safety of a Purified Standardised Bee Venom Preparation
NCT00263952 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2013-03-04
Summary
The trial is performed to assess efficacy and safety of a purified standardised bee venom preparation in bee venom allergy
Conditions
- Bee Venom Allergy
Interventions
- BIOLOGICAL
-
bee venom
Sponsors & Collaborators
-
Allergopharma GmbH & Co. KG
lead INDUSTRY
Principal Investigators
-
Annemie Narkus, M.D.
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-03-31
- Primary Completion
- 2005-01-31
- Completion
- 2010-04-30
Countries
- Germany
Study Locations
More Related Trials
-
Comparison of Skin Prick Testing and Intradermal Skin Test Result of Local and Imported Insect Allergen Extracts
NCT03645291 ·Status: COMPLETED ·Phase: NA
-
Performance of CAST (Cellular Antigen Stimulation Test) in Patients With Wasp Venom Allergy: Evaluation of Neutralizing IgG Subclasses
NCT00794287 ·Status: WITHDRAWN
-
Skin Tests in Cat Allergic Patients With Cat Dander Samples Obtained Before and After Vaccinating the Cat
NCT02667379 ·Status: COMPLETED ·Phase: NA
-
Tolerance in Beekeepers
NCT06156046 ·Status: RECRUITING
-
Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization
NCT04248556 ·Status: COMPLETED ·Phase: NA
-
Detection of Aluminium-reactive T-lymphocytes in Patients With Vaccination Granulomas
NCT06130462 ·Status: COMPLETED ·Phase: NA
-
Adding a Short Burst of Corticosteroid to the Conventional Treatment of H1 Antihistamines in Emergency Department.
NCT03296358 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of Lyral® Dose Response Study
NCT02028182 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of the Influence of Different Skin Conditions on the Allergic Skin Reactivity to Epicutanous Allergen Exposure
NCT02074930 ·Status: COMPLETED ·Phase: NA
-
Quaternium-15, Use Test
NCT00311454 ·Status: UNKNOWN ·Phase: PHASE4
-
The Causative Insects in Severe Insect Sting Allergy
NCT02764242 ·Status: COMPLETED ·Phase: NA
-
Study of Autologous Total Immunoglobulin G Therapy for Atopic Dermatitis
NCT02835170 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Penicillin Allergy Delabeling Among Surgical Patients
NCT05956080 ·Status: UNKNOWN ·Phase: NA
-
Physiological Study to Determine the Allergic Skin Activity After Different Skin Preparation
NCT01628484 ·Status: COMPLETED ·Phase: PHASE1
-
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.
NCT02932891 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis
NCT05498467 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Irritancy/Allergic Sensitivity to Natural Personal-care Products by Patch Tests
NCT01816542 ·Status: UNKNOWN ·Phase: NA
-
Penicillin Allergy Testing and Resensitization Rate
NCT03942731 ·Status: COMPLETED
-
Treating Patients With a History of Non-Life Threatening Allergic Reaction to Penicillin With Penicillin
NCT00363688 ·Status: TERMINATED ·Phase: PHASE4
-
Atopy Patch Test in Normal Population : Pilot Study
NCT01156038 ·Status: COMPLETED ·Phase: PHASE1
-
Novel Skin Care for Immunotherapy- Related Dermatologic Toxicities
NCT04929834 ·Status: UNKNOWN ·Phase: NA
-
Urtica Comp. Gel for Prevention and Therapy of Radiation Dermatitis
NCT03494205 ·Status: COMPLETED ·Phase: PHASE2
-
Allergic Disease Onset Prevention Study
NCT05003804 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Risk-stratified Testing for Safe Removal of Penicillin Allergy Labels
NCT06755281 ·Status: RECRUITING ·Phase: NA
-
The Frequency of Positive Challenge Test to Penicillin in Children Suspected to Have Allergy to Penicillin
NCT02702349 ·Status: UNKNOWN ·Phase: NA